Companies: 10,795·Total market cap: $144.5T
Roivant Sciences Ltd.

Roivant Sciences Ltd.

ROIVNASDAQHealthcare● Active
$28.49
$-0.09(-0.31%)
Market Cap$20.5B
P/E Ratio
52W High$32.793
52W Low$10.705
Overview

Roivant Sciences Ltd.(ROIV)· 现金流量表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ROIV · 截至 2026-06-10

财务报表

Operating CF · CapEx · Free Cash Flow
Breakdown2026-032025-032024-032023-032022-03
Operating Activities
Net Income($397.91M)($356.73M)$4231.21M($1115.46M)($924.12M)
Depreciation & Amort.$3.35M$14.07M$22.04M$18.86M$5.93M
Stock-Based Comp.$346.17M$289.03M$199.63M$217.78M$564.96M
Change in Working Capital($621.80M)($77.05M)$19.04M$6.34M$15.72M
Net Cash from Operations($750.35M)($839.45M)($765.27M)($843.39M)($677.73M)
Investing Activities
Capital Expenditure($8.21M)($4.60M)($1.38M)($12.69M)($17.44M)
Purchases of Investments$0.00M($4061.52M)$0.00M$0.00M$0.00M
Sales of Investments($37.49M)$1960.00M$0.00M$0.00M$320.17M
Net Cash from Investing($682.33M)($1766.29M)$5203.62M($44.27M)$303.30M
Financing Activities
Common Stock Repurchased($319.50M)($1293.23M)$0.00M$0.00M$0.00M
Dividends Paid$0.00M$0.00M($6.00M)$0.00M$0.00M
Debt Issued / Repaid$0.00M($52.75M)($30.70M)$129.75M$14.81M
Net Cash from Financing$134.24M($1219.79M)$419.36M$499.46M$306.79M
Free Cash Flow
Free Cash Flow($758.56M)($844.05M)($766.65M)($856.08M)($695.16M)
FCF Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · M

深入了解Roivant Sciences Ltd.

关于Roivant Sciences Ltd.(ROIV)现金流量表

Roivant Sciences Ltd. 2026财年经营活动现金流($0.75B),自由现金流($0.76B)(FCF利润率-9183.51%),资本支出($0.01B)。

常见问题

ROIV · 4 问

Roivant Sciences Ltd. 2026财年自由现金流($0.76B),同比up10.1%。

ROIV free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10